Explore our media store

Choose your required content type and access a wide range of materials relating to our company, people, medicines and diagnostic tools.

Media Releases

All

Published on: 22 September 2017

Roche receives EU approval of TECENTRIQ® (atezolizumab) in a specific type of metastatic lung cancer and two types of metastatic bladder cancer

Roche today announced that the European Commission (EC) has granted a marketing authorisation for TECENTRIQ (atezolizumab) as a monotherapy for the treatment of people with locally advanced or ...

Published on: 22 September 2017

Roche receives EU approval of Gazyvaro for people with previously untreated advanced follicular lymphoma

Roche announced today that the European Commission has approved Gazyvaro® (obinutuzumab) in combination with chemotherapy, followed by Gazyvaro maintenance in people achieving a response, as a new ...

Published on: 22 September 2017

Roche receives European approval for Actemra /RoActemra in giant cell arteritis

Roche announced today that the European Commission (EC) has approved Actemra®/RoActemra® (tocilizumab) for the treatment of giant cell arteritis (GCA), a chronic and potentially life-threatening ...